{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T22:24:06Z","timestamp":1789079046270,"version":"build-2803163510"},"reference-count":56,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T00:00:00Z","timestamp":1594339200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Background: Dyslipidemias are a heterogeneous group of metabolic disorders mainly characterized by an increased risk of atherosclerotic cardiovascular disease (ASCVD) or other conditions, such as acute pancreatitis in hypertriglyceridemia. The aim of this study was to evaluate the effect of diet treatment and nutraceutical (NUTs) supplementation on the plasma lipid profile in outpatient dyslipidemic subjects, considering the influence of several factors (i.e., gender, age, body mass index, alcohol consumption, and smoking habits). Methods: 487 dyslipidemic patients spanning from 2015 to 2019 were treated with a Mediterranean diet or NUTs in a real-word setting and were retrospectively analyzed. General characteristics and lipid profile at baseline and after the follow-up period were evaluated. Results: Diet alone reduced total cholesterol (\u221219 mg\/dL, \u22127.7%), LDL cholesterol (\u221218 mg\/dL, \u221210.1%), and triglycerides (\u221220 mg\/dL, \u221216.7%). Triglycerides (TG) decreased more in men, while women were associated with higher reduction of LDL cholesterol (LDL-C). Different types of NUTs further ameliorate lipid profiles when associated with diet. Nevertheless, most patients at low ASCVD risk (222 out of 262, 81.6%) did not achieve the 2019 ESC\/EAS guidelines recommended LDL-C goals (i.e., LDL-C &lt; 116 mg\/dL). Conclusion: Lipid-lowering diet improves lipid profile, and NUTs can boost its efficacy, but taken together they are mainly unsatisfactory with respect to the targets imposed by 2019 EAS\/ESC guidelines.<\/jats:p>","DOI":"10.3390\/nu12072056","type":"journal-article","created":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T04:46:01Z","timestamp":1594701961000},"page":"2056","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Diet and Nutraceutical Supplementation in Dyslipidemic Patients: First Results of an Italian Single Center Real-World Retrospective Analysis"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1791-4506","authenticated-orcid":false,"given":"Andrea","family":"Pasta","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, University of Genoa, 16132 Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2585-4566","authenticated-orcid":false,"given":"Elena","family":"Formisano","sequence":"additional","affiliation":[{"name":"Nutritional Unit ASL-1 Imperiese, Giovanni Borea Civil Hospital, 18038 Sanremo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8691-2371","authenticated-orcid":false,"given":"Anna Laura","family":"Cremonini","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Genoa, 16132 Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elio","family":"Maganza","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Genoa, 16132 Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Parodi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Genoa, 16132 Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Piras","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Genoa, 16132 Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Livia","family":"Pisciotta","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Genoa, 16132 Genoa, Italy"},{"name":"Dietetics and Clinical Nutrition Unit, IRCCS Policlinic Hospital San Martino, 16132 Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,7,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0095-4543(05)70164-0","article-title":"Hyperlipidemia","volume":"27","author":"Yu","year":"2000","journal-title":"Prim. Care"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.pop.2012.11.003","article-title":"Hyperlipidemia as a Risk Factor for Cardiovascular Disease","volume":"40","author":"Nelson","year":"2013","journal-title":"Prim. Care"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"191","DOI":"10.4103\/1947-2714.132916","article-title":"Atherosclerotic Cardiovascular Disease Risk and Evidence-based Management of Cholesterol","volume":"6","author":"Roy","year":"2014","journal-title":"N Am. J. Med. Sci."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.cca.2018.09.010","article-title":"Dyslipidemias in clinical practice","volume":"487","author":"Cabezas","year":"2018","journal-title":"Clin. Chim. Acta"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/01.mcg.0000436438.60145.5a","article-title":"Issues in hypertriglyceridemic pancreatitis: An update","volume":"48","author":"Scherer","year":"2014","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/00041433-199608000-00007","article-title":"Hypoalphalipoproteinemia (low high density lipoprotein) as a risk factor for coronary heart disease","volume":"7","author":"Vega","year":"1996","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1001\/jamacardio.2016.4320","article-title":"Statins and the Prevention of Heart Disease","volume":"2","author":"Ziaeian","year":"2017","journal-title":"JAMA Cardiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11883-011-0219-7","article-title":"Residual cardiovascular risk despite optimal LDL cholesterol reduction with statins: The evidence, etiology, and therapeutic challenges","volume":"14","author":"Sampson","year":"2012","journal-title":"Curr. Atheroscler. Rep."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"655","DOI":"10.2217\/clp.10.49","article-title":"Update on the efficacy and safety of combination ezetimibe plus statin therapy","volume":"5","author":"Toth","year":"2010","journal-title":"Clin. Lipidol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.atherosclerosis.2012.02.016","article-title":"Lipid-altering efficacy of ezetimibe plus statin and statin monotherapy and identification of factors associated with treatment response: A pooled analysis of over 21,000 subjects from 27 clinical trials","volume":"223","author":"Morrone","year":"2012","journal-title":"Atherosclerosis"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1080\/14656566.2019.1702970","article-title":"PCSK9 inhibitors for treating hypercholesterolemia","volume":"21","author":"Pasta","year":"2020","journal-title":"Expert Opin. Pharm."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/CRD.0b013e31816b43d3","article-title":"Fibrate therapy: An update","volume":"16","author":"Remick","year":"2008","journal-title":"Cardiol. Rev."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1093\/eurheartj\/ehw272","article-title":"2016 ESC\/EAS Guidelines for the Management of Dyslipidaemias","volume":"37","author":"Catapano","year":"2016","journal-title":"Eur. Heart J."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"American Heart Association Nutrition Committee, Lichtenstein, A.H., Appel, L.J., Brands, M., Carnethon, M., Daniels, S., Franch, H.A., Franklin, B., Kris-Etherton, P., and Harris, W.S. (2006). Diet and lifestyle recommendations revision 2006: A scientific statement from the American Heart Association Nutrition Committee. Circulation, 114, 82\u201396.","DOI":"10.1161\/CIRCULATIONAHA.106.176158"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1753-4887.1997.tb01578.x","article-title":"Healthy traditional Mediterranean diet: An expression of culture, history, and lifestyle","volume":"55","author":"Trichopoulou","year":"1997","journal-title":"Nutr. Rev."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ecl.2015.09.012","article-title":"Management of Hypertriglyceridemia for Prevention of Atherosclerotic Cardiovascular Disease","volume":"45","author":"Brinton","year":"2016","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/ajcn\/74.1.80","article-title":"Effects on blood lipids of a blood pressure-lowering diet: The Dietary Approaches to Stop Hypertension (DASH) Trial","volume":"74","author":"Obarzanek","year":"2001","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1001\/jama.294.19.2455","article-title":"Effects of protein, monounsaturated fat, and carbohydrate intake on blood pressure and serum lipids: Results of the OmniHeart randomized trial","volume":"294","author":"Appel","year":"2005","journal-title":"JAMA"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1161\/01.ATV.18.3.441","article-title":"Effects of reducing dietary saturated fatty acids on plasma lipids and lipoproteins in healthy subjects: The DELTA Study, protocol 1","volume":"18","author":"Ginsberg","year":"1998","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1093\/ajcn\/65.3.823","article-title":"Individual variability in lipoprotein cholesterol response to National Cholesterol Education Program Step 2 diets","volume":"65","author":"Schaefer","year":"1997","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jacc.2018.04.040","article-title":"The Role of Nutraceuticals in Statin Intolerant Patients","volume":"72","author":"Banach","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.2174\/1381612823666170317145851","article-title":"Nutraceuticals as an Important Part of Combination Therapy in Dyslipidaemia","volume":"23","author":"Patti","year":"2017","journal-title":"Curr. Pharm. Des."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1093\/nutrit\/nux047","article-title":"Lipid-lowering nutraceuticals in clinical practice: Position paper from an International Lipid Expert Panel","volume":"75","author":"Cicero","year":"2017","journal-title":"Nutr. Rev."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12944-016-0286-4","article-title":"The clinical relevance of omega-3 fatty acids in the management of hypertriglyceridemia","volume":"15","author":"Backes","year":"2016","journal-title":"Lipids Health Dis."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.numecd.2017.11.001","article-title":"Hypertriglyceridemia and omega-3 fatty acids: Their often overlooked role in cardiovascular disease prevention","volume":"28","author":"Arca","year":"2018","journal-title":"Nutr. Metab. Cardiovasc Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1592\/phco.27.5.715","article-title":"Role of prescription omega-3 fatty acids in the treatment of hypertriglyceridemia","volume":"27","author":"McKenney","year":"2007","journal-title":"Pharmacotherapy"},{"key":"ref_28","unstructured":"(2020, March 15). Nota 13|Agenzia Italiana del Farmaco, Available online: https:\/\/aifa.gov.it\/nota-13."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0195-668X(03)00114-3","article-title":"Estimation of ten-year risk of fatal cardiovascular disease in Europe: The SCORE project","volume":"24","author":"Conroy","year":"2003","journal-title":"Eur. Heart J."},{"key":"ref_30","unstructured":"(1998). Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults\u2014The Evidence Report. National Institutes of Health, National Heart, Lung, and Blood Institute."},{"key":"ref_31","unstructured":"(2020, April 25). Population Structure and Ageing\u2014Statistics Explained. Available online: https:\/\/ec.europa.eu\/eurostat\/statistics-explained\/index.php?title=Population_structure_and_ageing#Median_age_is_highest_in_Italy."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/JCN.0000000000000089","article-title":"Adherence to the Low Sodium Diet in Patients with Heart Failure is Best When Family Members Also Follow the Diet: A Multicenter Observational Study","volume":"30","author":"Chung","year":"2015","journal-title":"J. Cardiovasc Nurs."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s40842-018-0070-7","article-title":"Level of adherence to dietary recommendations and barriers among type 2 diabetic patients: A cross-sectional study in an Ethiopian hospital","volume":"4","author":"Ayele","year":"2018","journal-title":"Clin. Diabetes Endocrinol."},{"key":"ref_34","first-page":"479","article-title":"Adherence to Medication, Diet and Physical Activity and the Associated Factors Amongst Patients with Type 2 Diabetes","volume":"11","author":"Mirahmadizadeh","year":"2020","journal-title":"Diabetes"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s12325-016-0462-y","article-title":"A Review of Clinical Practice Guidelines for the Management of Hypertriglyceridemia: A Focus on High Dose Omega-3 Fatty Acids","volume":"34","author":"Karalis","year":"2017","journal-title":"Adv. Ther."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ejim.2008.06.011","article-title":"Gender differences in the lipid profile of dyslipidemic subjects","volume":"20","author":"Kolovou","year":"2009","journal-title":"Eur. J. Intern. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.repc.2019.02.009","article-title":"DISGEN-LIPID study Investigators Suboptimal lipid levels in clinical practice among Portuguese adults with dyslipidemia under lipid-lowering therapy: Data from the DISGEN-LIPID study","volume":"38","author":"Aguiar","year":"2019","journal-title":"Rev. Port. Cardiol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1177\/2010105817694906","article-title":"A cross-sectional study of gender differences in lifestyle behavior and usage of medications among community-dwelling Asians towards achieving their LDL-Cholesterol treatment goals","volume":"26","author":"Tan","year":"2017","journal-title":"Proc. Singap. Healthc."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/1476-511X-10-176","article-title":"New insights into the mechanism of low high-density lipoprotein cholesterol in obesity","volume":"10","author":"Wang","year":"2011","journal-title":"Lipids Health Dis"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.orcp.2016.04.007","article-title":"Associations between hypo-HDL cholesterolemia and cardiometabolic risk factors in middle-aged men and women: Independence of habitual alcohol drinking, smoking and regular exercise","volume":"11","author":"Wakabayashi","year":"2017","journal-title":"Obes Res. Clin. Pr."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.jadohealth.2017.10.001","article-title":"Tobacco Smoke Exposure Association with Lipid Profiles and Adiposity Among U.S. Adolescents","volume":"62","author":"Merianos","year":"2018","journal-title":"J. Adolesc Health"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"830","DOI":"10.7326\/0003-4819-150-12-200906160-00006","article-title":"Red yeast rice for dyslipidemia in statin-intolerant patients: A randomized trial","volume":"150","author":"Becker","year":"2009","journal-title":"Ann. Intern. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3109\/14017431003624123","article-title":"HypoCol (red yeast rice) lowers plasma cholesterol\u2014A randomized placebo controlled study","volume":"44","author":"Bogsrud","year":"2010","journal-title":"Scand. Cardiovasc. J."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s00394-012-0357-x","article-title":"LDL-cholesterol-lowering effect of a dietary supplement with plant extracts in subjects with moderate hypercholesterolemia","volume":"52","author":"Ogier","year":"2013","journal-title":"Eur. J. Nutr."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"882","DOI":"10.3109\/09637486.2013.809405","article-title":"A combined natural supplement lowers LDL cholesterol in subjects with moderate untreated hypercholesterolemia: A randomized placebo-controlled trial","volume":"64","author":"Barrat","year":"2013","journal-title":"Int J. Food Sci. Nutr."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1007\/s00394-012-0486-2","article-title":"Effect on LDL-cholesterol of a large dose of a dietary supplement with plant extracts in subjects with untreated moderate hypercholesterolaemia: A randomised, double-blind, placebo-controlled study","volume":"52","author":"Barrat","year":"2013","journal-title":"Eur. J. Nutr."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.clnu.2011.10.008","article-title":"Reduction of serum lipids by the intake of the extract of garlic fermented with Monascus pilosus: A randomized, double-blind, placebo-controlled clinical trial","volume":"31","author":"Higashikawa","year":"2012","journal-title":"Clin. Nutr."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosissup.2016.10.003","article-title":"A nutraceutical approach (Armolipid Plus) to reduce total and LDL cholesterol in individuals with mild to moderate dyslipidemia: Review of the clinical evidence","volume":"24","author":"Barrios","year":"2017","journal-title":"Atheroscler. Suppl."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Formisano, E., Pasta, A., Cremonini, A.L., Favari, E., Ronca, A., Carbone, F., Semino, T., Di Pierro, F., Sukkar, S.G., and Pisciotta, L. (2019). Efficacy of Nutraceutical Combination of Monacolin K, Berberine, and Silymarin on Lipid Profile and PCSK9 Plasma Level in a Cohort of Hypercholesterolemic Patients. J. Med. Food.","DOI":"10.1089\/jmf.2019.0168"},{"key":"ref_50","first-page":"1555","article-title":"Effect of a novel nutraceutical combination on serum lipoprotein functional profile and circulating PCSK9","volume":"13","author":"Adorni","year":"2017","journal-title":"Clin. Risk Manag."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ijcard.2008.03.092","article-title":"Benefits of fish oil supplementation in hyperlipidemia: A systematic review and meta-analysis","volume":"136","author":"Eslick","year":"2009","journal-title":"Int. J. Cardiol."},{"key":"ref_52","unstructured":"Abramson, J. (2017). Statins in Persons at Low Risk of Cardiovascular Disease. Am. Fam Physician, 96."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0140-6736(12)60367-5","article-title":"The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: Meta-analysis of individual data from 27 randomised trials","volume":"380","author":"Mihaylova","year":"2012","journal-title":"Lancet"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(12)61190-8","article-title":"Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: An analysis from the JUPITER trial","volume":"380","author":"Ridker","year":"2012","journal-title":"Lancet"},{"key":"ref_55","first-page":"631","article-title":"Statin Therapy: Review of Safety and Potential Side Effects","volume":"32","author":"Ramkumar","year":"2016","journal-title":"Acta Cardiol. Sin."},{"key":"ref_56","first-page":"487","article-title":"Analysis of factors associated with statin adherence in a hierarchical model considering physician, pharmacy, patient, and prescription characteristics","volume":"13","author":"Pedan","year":"2007","journal-title":"J. Manag. Care Pharm."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/12\/7\/2056\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:50:02Z","timestamp":1760176202000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/12\/7\/2056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,10]]},"references-count":56,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,7]]}},"alternative-id":["nu12072056"],"URL":"https:\/\/doi.org\/10.3390\/nu12072056","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,10]]}}}